References
- Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74
- Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy. Sydney: Society Of Obstetric Medicine Of Australia and New Zealand; 2001. Available at: https://Somanz.Org/Documents/Htpregnancyguidelinejuly2014.Pdf [last accessed 3 Nov 2014]
- Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911–19
- Barker DJ. The origins of the developmental origins theory. J Intern Med 2007;261:412–17
- Wagner SJ, Craici IM, Grande JP, et al. From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia. Clin Nephrol 2012;78:241–9
- Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble Fms-like tyrosine kinase 1 (Sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
- Camici M. Urine biomarkers of podocyte injury. Biomark Med 2008;2:613–16
- Camici M. Urine detection of podocyte injury. Biomed Pharmacother 2007;61:245–9
- Welsh GI, Saleem MA. Nephrin – signature molecule of the glomerular podocyte? J Pathol 2010;220:328–37
- Kestila M, Lenkkeri U, Mannikko M, et al. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575–82
- Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013;9:328–36
- Kandasamy Y, Smith R, Lumber ER, Rudd D. Nephrin – a biomarker of early glomerular injury. Biomark Res 2014;2:21
- Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte ecretion as a marker for preeclampsia. Am J Obstet Gynecol 2007;196:320.E1–7
- Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008;294:F1185–94
- Son GH, Kim JH, Hwang JH, et al. Urine excretion of nephrin in patients with severe preeclampsia. Hypertens Pregnancy 2011;30:408–13
- Son GH, Kwon JY, Lee S, et al. Comparison of serum and urine nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2013;166:139–44
- Wang Y, Zhao S, Loyd S, Groome LJ. Increased urine excretion of nephrin, podocalyxin, and (Beta)Ig-H3 in women with preeclampsia. Am J Physiol Ren Physiol 2012;302:F1084–9
- Mehta S, Qipo A, Sharma S, et al. Urine albumin vs. urine nephrin in predicting the development of preeclampsia. Am J Kidney Dis 2012;59:A56
- Jim B, Mehta S, Qipo A, et al. A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study. PLoS One 2014;9:E101445
- Yang GY, Lee KA, Park MH, et al. Urine nephrin: a new predictive marker for pregnancies with preeclampsia and small-for-gestational age infants. Obstet Gynecol Sci 2013;56:22–8
- ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia, Number 33, January 2002. Obstet Gynecol 2002;99:159–67